Skip to main content
Log in

Evolution of Visceral Sensitivity in Patients with Irritable Bowel Syndrome

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Irritable bowel syndrome (IBS) has been associated with visceral hypersensitivity. Here we examined the evolution of rectal sensitivity and of gastrointestinal symptomatology in IBS patients over time, to verify if the clinical and biological parameters showed parallel behavior. Patients complaining of IBS, identified by Rome 1 criteria, were included in this study. The severity of the gastrointestinal (Gastrointestinal) symptoms was assessed by a gastrointestinal index. The pain threshold to rectal distension was measured by a barostat programmed for phasic ascending distensions. Both measures were obtained before and after treatment. Thirty-nine patients were followed while on a 10-week group psychotherapy (psy) program. Twelve patients were controlled after pharmacological treatment with amitriptyline (Ami) 10 mg hours for two weeks and then 25 mg hours for the following 4 weeks. Clinical improvement with symptom reduction was achieved in both patients groups. With psy, the Gastrointestinal index declined from an initial value of 78.4 ± 4.8 to 65.5 ± 4.5 at the end of treatment (P < 0.05). With Ami, the gastrointestinal index decreased from 91.6 ± 5.6 to 61.8 ± 9.1 (p < 0.01). The pain threshold to rectal distension increased from 27.7 ± 1.0 to 33.7 ± 1.9 mmHg (P < 0.01) after drug treatment, but remained unchanged (30.6 ± 1.0 vs 30.6 ± 1.1 mm Hg) with psy. Evolution of the gastrointestinal index and rectal sensitivity were directly correlated (r = −0.71; P < 0.01) in Ami patients, but not in those treated with Psy (r = −0.001). In conclusion, visceral hypersensitivity appeared as a stable biological defect over a 10- to 12-week period during clinically-effective treatment with psychotherapy. Rectal pain threshold, however, seemed to be pharmacologically manipulatable in patients treated with Ami.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. Ritchie J: Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome. Gut 14:125–132, 1973

    PubMed  Google Scholar 

  2. Whitehead WE, Holtkotter B, Enck P, Hoelzl R, Holmes KD, Anthony J, Shabsin H, Schuster M: Tolerance for rectosigmoid distention in irritable bowel syndrome. Gastroenterology 98:1187–1192, 1990

    PubMed  Google Scholar 

  3. Bradette M, Delvaux M, Staumont G, Fioramonti J, Bueno L, Frexinos J: Evaluation of colonic sensory thresholds in IBS patients using a barostat. Dig Dis Sci 39(3):449–457, 1994

    PubMed  Google Scholar 

  4. Mayer EA, Gebhart GF: Basic and clinical aspects of visceral hyperalgesia. Gastroenterology 107:271–293, 1994

    PubMed  Google Scholar 

  5. Mertz H, Naliboff B, Munakata J, Niazi N, Mayer EA: Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 109:40–52, 1995

    PubMed  Google Scholar 

  6. Camilleri M, Coulie B, Tack J: Visceral hypersensitivity: facts, speculations, and challenges. Gut 48(1):125–131, 2001

    PubMed  Google Scholar 

  7. Thompson WG, Creed F, Drossman DA, Heaton KW, Mazzacca G: Functional bowel disease and functional abdominal pain. Gastroenterol Int 5(2):75–91, 1992

    Google Scholar 

  8. Plourde V, Boivin M, Poitras P, Devroede G, Giguère A: The visceral hypersensitivity and abnormal referral pain patterns in patients with irritable bowel syndrome: predictive value of clinical factors. Gastroenterology 112:A807, 1997

    Google Scholar 

  9. Riberdy Poitras M, Verrier P, So C, Paquette S, Bouin M, Poitras P: Group counseling psychotherapy for patients with functional gastrointestinal disorders. Dig Dis Sci (submitted)

  10. Boivin M, Poitras P, Lahaie RG, Plourde V: Visceral sensitization in functional bowel disorders occurs predominantly in painful disorders. Gastroenterology 114(4):G2991, 1998

    Google Scholar 

  11. Trimble KC, Farouk R, Pryde A, Douglas S, Heading RC: Heightened visceral sensation in functional GI disease is not site specific. Evidence for a generalized disorder of gut sensitivity. Dig Dis Sci 40:1607–1613, 1995

    PubMed  Google Scholar 

  12. Desautels S, Slivka A, Hutson WR, Chun A, Mitrani C, Dilorenzo C, Wald A: Postcholecystectomy pain syndrome: pathophysiology of abdominal pain in sphincter of Oddi type III. Gastroenterology 116:900–905, 1999

    PubMed  Google Scholar 

  13. Whitehead WE, Palsson OS: Is rectal pain sensitivity a biological marker for irritable bowel syndrome: psychological influences on pain perception. Gastroenterology 115:1263–1271, 1998

    PubMed  Google Scholar 

  14. Blanc C, Delvaux M, Maillot C, Bouin M, Lagier E, Fioramonti J, Buéno L, Frexinos J: Distension protocols for evaluation of rectal sensitivity: the simplest, the best? Gastroenterology 114(4):G2987, 1998

    Google Scholar 

  15. Heymann-Mönnikes I, Arnold R, Florin I, Herda C, Melfsen S, Mönnikes H: Combination of medical treatment plus multicomponent behavioral therapy is superior to medical treatment alone in the therapy of irritable bowel syndrome. Am J Gastroenterol 95:981–994, 2000

    PubMed  Google Scholar 

  16. Prior A, Colgan SM, Whorwell PJ: Changes in rectal sensitivity after hypnotherapy in patients with irritable bowel syndrome. Gut 31:896–896, 1990

    PubMed  Google Scholar 

  17. Palsson OS, Burnett CK, Meyer K, Whitehead WE: Hypnosis treatment for irritable bowel syndrome: effects on symptoms, pain threshold, and muscle tone. Gastroenterology 112:A803, 1997

    Google Scholar 

  18. Delvaux M, Louvel D, Lagier E, Scherrer B, Abitbol JL, Frexinos J: The kappa agonist fedotozine relieves hypersensitivity to colonic distention in patients with irritable bowel syndrome. Gastroenterology 116(1):38–45, 1999

    PubMed  Google Scholar 

  19. Delvaux M, Louvel D, Mamet JP, Campos-Oriola R, Frexinos J: Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome. Aliment Pharmacol Ther (9):849–855, 1998

    Google Scholar 

  20. Clouse RE, Lustman PJ, Geisman RA, Alpers DH: Antidepressant therapy in 138 patients with IBS. Aliment Pharmacol Ther 8:409–416, 1994

    PubMed  Google Scholar 

  21. Drossman DA, Whitehead WE, Camilleri M: Irritable bowel syndrome: A technical review for practice guideline development. Gastroenterology 112:2120–2137, 1997

    PubMed  Google Scholar 

  22. Gorelick AB, Kosh SS, Hooper FG, Bennett TC, Chey WD, Hasler WL: Differential effects of amitriptyline on perception of somatic and visceral stimulation in healthy humans. Am J Physiol 275(3 Pt1):G460–G466, 1998

    PubMed  Google Scholar 

  23. Mertz H, Fass R, Kodner A, Yan-Go F, Fullerton S, Mayer EA: Effect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia. Am J Gastroenterol 93(2):160–165, 1998

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Poitras, P., Poitras, M.R., Plourde, V. et al. Evolution of Visceral Sensitivity in Patients with Irritable Bowel Syndrome. Dig Dis Sci 47, 914–920 (2002). https://doi.org/10.1023/A:1014729125428

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1014729125428

Navigation